SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-23-003917
Filing Date
2023-06-14
Accepted
2023-06-14 08:35:54
Documents
2
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_061423.htm 6-K 6936
2 PRESS RELEASE exh_991.htm EX-99.1 5202
  Complete submission text file 0001171843-23-003917.txt   13260
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37652 | Film No.: 231013070
SIC: 2834 Pharmaceutical Preparations